PCRX FY 2011 Earnings — Pacira BioSciences, Inc. Revenue & Financial Results | Market Cap Arena

PCRXPacira BioSciences, Inc.

$976M

FY 2011 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$16M+7.7% YoY

Gross Profit

-$1M-6.7% margin

Operating Income

-$39M-249.2% margin

Net Income

-$43M-276.2% margin

EPS (Diluted)

$-2.64

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$37M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$113M

Total Liabilities

$65M

Stockholders' Equity

$48M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$15M	+7.7%
Gross Profit	-$1M	$2M	-145.9%
Operating Income	-$39M	-$22M	-74.8%
Net Income	-$43M	-$27M	-59.6%